First Bank & Trust Pfizer Inc Transaction History

First Bank & Trust

$584 Million
Q3 2025

A detailed history of First Bank & Trust transactions in Pfizer Inc stock. As of the latest transaction made, First Bank & Trust holds 151,617 shares of PFE stock, worth $3.74 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

151,617

Previous 71,216 112.9%

Holding current value

$3.74 Million

Previous $1.73 Million 123.81%

% of portfolio

0.66%

Previous 0.32%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 10, 2025	BUY	$23.29 - $25.88 $1.87 Million - $2.08 Million	80,401 Added 112.9%	151,617 $3.86 Million
Q2 2025 Jul 09, 2025	BUY	$21.59 - $24.84 $37,523 - $43,171	1,738 Added 2.5%	71,216 $1.73 Million
Q1 2025 Apr 28, 2025	BUY	$25.01 - $27.13 $76,605 - $83,099	3,063 Added 4.61%	69,478 $1.76 Million
Q4 2024 Feb 03, 2025	SELL	$24.8 - $30.19 $279,744 - $340,543	-11,280 Reduced 14.52%	66,415 $1.76 Million
Q3 2024 Oct 24, 2024	BUY	$27.7 - $31.39 $68,114 - $77,188	2,459 Added 3.27%	77,695 $2.25 Million
Q2 2024 Jul 09, 2024	BUY	$25.26 - $29.6 $87,172 - $102,149	3,451 Added 4.81%	75,236 $2.11 Million
Q1 2024 Apr 17, 2024	BUY	$25.89 - $29.73 $759,664 - $872,337	29,342 Added 69.13%	71,785 $1.99 Million
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $480,426 - $624,020	-18,386 Reduced 30.23%	42,443 $1.22 Million
Q3 2023 Oct 11, 2023	SELL	$32.09 - $37.51 $14,536 - $16,992	-453 Reduced 0.74%	60,829 $2.02 Million
Q2 2023 Jul 12, 2023	BUY	$36.12 - $41.79 $378,212 - $437,583	10,471 Added 20.61%	61,282 $2.25 Million
Q1 2023 Apr 25, 2023	BUY	$39.39 - $51.28 $363,609 - $473,365	9,231 Added 22.2%	50,811 $2.07 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $135,478 - $176,852	3,245 Added 8.46%	41,580 $2.13 Million
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $64,327 - $78,527	1,470 Added 3.99%	38,335 $1.68 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $17,076 - $20,247	-367 Reduced 0.99%	36,865 $1.93 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $52,978 - $65,647	-1,158 Reduced 3.02%	37,232 $1.93 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $1.32 Million - $1.96 Million	-31,949 Reduced 45.42%	38,390 $2.27 Million
Q3 2021 Oct 18, 2021	SELL	$39.25 - $50.42 $116,376 - $149,495	-2,965 Reduced 4.04%	70,339 $3.02 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $250,041 - $283,254	6,963 Added 10.5%	73,304 $2.87 Million
Q1 2021 Apr 14, 2021	BUY	$33.49 - $37.77 $165,273 - $186,394	4,935 Added 8.04%	66,341 $2.4 Million
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $7,731 - $9,831	-231 Reduced 0.37%	61,406 $2.26 Million
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $44,227 - $51,889	1,393 Added 2.31%	61,637 $2.26 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $358,337 - $434,716	-11,897 Reduced 16.49%	60,244 $1.97 Million
Q1 2020 Apr 14, 2020	BUY	$27.03 - $38.62 $541,410 - $773,558	20,030 Added 38.44%	72,141 $2.35 Million
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $355,009 - $402,890	10,784 Added 26.09%	52,111 $2.04 Million
Q3 2019 Oct 17, 2019	BUY	$32.49 - $42.13 $1.22 Million - $1.58 Million	37,409 Added 954.8%	41,327 $1.49 Million
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $119,445 - $134,109	-3,230 Reduced 45.19%	3,918 $170,000
Q1 2019 Apr 15, 2019	SELL	$37.5 - $41.2 $43,500 - $47,792	-1,160 Reduced 13.96%	7,148 $304,000
Q4 2018 Jan 28, 2019	SELL	$38.47 - $43.86 $410,205 - $467,679	-10,663 Reduced 56.21%	8,308 $363,000
Q3 2018 Oct 10, 2018	BUY	$34.47 - $41.81 $622,872 - $755,506	18,070 Added 2005.55%	18,971 $788,000
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $29,714 - $31,679	901 New	901 $33,000
Q4 2017 Jan 18, 2018	SELL	$33.26 - $35.29 $2,860 - $3,034	-86 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$31.0 - $34.15 $2,666 - $2,936	86	86 $3,000

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.

Account